Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Man sitting on a sofa leaning his face into his hands © Andrea Piacquadio from Pexels

Researchers from the Experimental Psychology Department and Nuffield Department of Clinical Neurosciences have shown that people who have had COVID, but don’t complain of long COVID symptoms in daily life, nevertheless can show degraded attention and memory for up to 6-9 months.

Previous studies have shown that after acute COVID-19 infection, some people can continue to suffer from cognitive symptoms such as difficulties in concentrating, colloquially referred to as brain fog, as well as forgetfulness and fatigue – features of the ‘long COVID’ syndrome.

But it was not known whether cognitive performance can also be affected in individuals who had mild symptoms and report no concerns after recovery from acute COVID infection.

In this study published today in Brain Communications, participants were asked to complete a number of exercises to test their memory and cognitive ability, with a focus on cognitive functions critical for daily life, such as sustaining attention, memory, planning and semantic reasoning.

All the participants had previously suffered from COVID-19 but were not significantly different from a control group at the time of testing on factors such as fatigue, forgetfulness, sleep patterns or anxiety.

The researchers found that the participants performed well in most abilities tested, including working memory and planning, but they displayed significantly worse episodic memory (up to 6 months post-COVID infection) and a greater decline in the ability to sustain attention over time (for up to 9 months) than uninfected individuals.

Dr Sijia Zhao from EP said: “What is surprising is that although our COVID-19 survivors did not feel any more symptomatic at the time of testing, they showed degraded attention and memory. Our findings reveal that people can experience some chronic cognitive consequences for months.”

Professor Masud Husain said: “We still do not understand the mechanisms that cause these cognitive deficits, but it is very encouraging to see that these attention and memory impairments return largely to normal in most people we tested by 6-9 months after infection, who demonstrated good recovery over time.”

 

The full paper, “Rapid vigilance and episodic memory decrements in COVID-19 survivors” can be read in Brain Communications: https://doi.org/10.1093/braincomms/fcab295.

Similar stories

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.